Home 禄 Business 禄 Manufacturing
Shanghai center
By Richard Fu |
May 12, 2011, Thursday
|
Print Edition
Print Edition
Merck Millipore, the life science division of Germany's Merck, launched a US$2 million China biopharmaceutical technology center in Shanghai yesterday to provide support, training and validation services to drug-making customers.
"We are responding to China's commitment to strengthening regulatory requirements designed to ensure drug safety," said Jean-Paul Mangeolle, head of Merck Millipore's process solutions business.
Merck KGaA, which relies heavily on liquid crystals, the key chemical for TV screens, and on multiple sclerosis and cancer drugs for earnings, acquired American biotech tool maker Millipore Corp last year to build its lab equipment business.
"We are responding to China's commitment to strengthening regulatory requirements designed to ensure drug safety," said Jean-Paul Mangeolle, head of Merck Millipore's process solutions business.
Merck KGaA, which relies heavily on liquid crystals, the key chemical for TV screens, and on multiple sclerosis and cancer drugs for earnings, acquired American biotech tool maker Millipore Corp last year to build its lab equipment business.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
